Evidence map›Paper›PMID 30804570›Full record

ArticleNature protocols2019

Holographic two-photon activation for synthetic optogenetics.

Ido Carmi, Marco De Battista, Laura Maddalena, Elizabeth C Carroll, Michael A Kienzler, Shai Berlin

Abstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Split genetically encoded calcium indicators for interorganellar junctions.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Modern Microscopic Approaches to Astrocytes.International journal of molecular sciences · 2023
    Review
  5. Article
  6. New tricks and emerging applications from contemporary azobenzene research.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2022
    Article
  7. Red Photoactivatable Genetic Optical-Indicators.Frontiers in cellular neuroscience · 2020
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Ido CarmiDepartment of Neuroscience, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Marco De BattistaDepartment of Neuroscience, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Laura MaddalenaDepartment of Imaging Physics, Delft University of Technology, Delft, the Netherlands.
Elizabeth C CarrollDepartment of Imaging Physics, Delft University of Technology, Delft, the Netherlands.
Michael A KienzlerDepartment of Chemistry, University of Maine, Orono, ME, USA.
Shai BerlinDepartment of Neuroscience, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. shai.berlin@technion.ac.il.ORCID http://orcid.org/0000-0002-5153-4876
Technion – Israel Institute of Technology · ILDelft University of Technology · NLUniversity of Maine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optogenetic tools provide users the ability to photocontrol the activity of cells. Commonly, activation is achieved by expression of proteins from photosynthetic organisms, for example, microbial opsins (e.g., ChR2). Alternatively, a sister approach, synthetic optogenetics, enables photocontrol over proteins of mammalian origin by use of photoswitches, visible light (typically), and genetic modification. Thus, synthetic optogenetics facilitates interrogation of native neuronal signaling mechanisms. However, the poor tissue penetration of visible wavelengths impedes the use of the technique in tissue, as two-photon excitation (2PE) is typically required to access the near-infrared window. Here, we describe an alternative technique that uses 2PE-compatible photoswitches (section 1) for photoactivation of genetically modified glutamate receptors (section 2). Furthermore, for fast, multi-region photoactivation, we describe the use of 2P-digital holography (2P-DH) (section 3). We detail how to combine 2P-DH and synthetic optogenetics with electrophysiology, or with red fluorescence Ca

Indexed as

PhotonsAmino Acid SequenceAnimalsAzo CompoundsFemaleHEK293 CellsHolographyHumansLigandsOptogeneticsProtein DomainsRats, Sprague-DawleyReceptors, GlutamateStereoisomerismazobenzeneAzo CompoundsLigandsReceptors, Glutamate

Identifiers

PMID30804570
OpenAlexW2915488495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.